Vistin Pharma

"Management adopts a balanced, operationally transparent tone — acknowledging clear headwinds (FX impact, lower ASP, Q4 maintenance stop) while highlighting genuine positives (8% volume growth, 66% gross margin, strong balance sheet, ESG positioning). For a healthcare/pharma company, this tone is typical: cautious on macro factors outside management control while confident on operational execution."